68
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Increased Fetal Iron Load in Rhesus Hemolytic Disease

, &
Pages 329-333 | Published online: 09 Jul 2009

REFERENCES

  • James D. Anti-D prophylaxis in 1997: The Edinburgh Consensus Statement. ArchDis Child Fetal Neona-talEd. 1998;78:F161- F165.
  • Berger HM, LindemanJHN, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HH. Iron overload, free radical damage and rhesus hemolytic disease. Lancet. 1990;335:933-936.
  • Nasrat HA, Nicolini U, Nicolaidis P, Letsky EA, Gau G, Rodeck CH. The effect of intrauterine intravascular blood transfusion on iron metabolism in fetuses with Rh alloimmunisation. Obstet Gynecol 1991;77:558-562.
  • Fleming RE. Cord serum ferritin levels, fetal iron status and neurodevelopmental outcomes: corre-lations and confounding variables. JPediatr. 2002;140:145-148.
  • Georgieff MK, Wewerka SW, Nelson CA, deRegnier RA. Iron status at 9 months of infants with low iron stores at birth. JPediatr. 2002;141:405-409.
  • Carpani G, Marini F, Ghisoni L, Buscaglia M, Sinigaglia E, Moroni G. Red cell and plasma ferritin in a group of normal fetuses at different ages of gestation. EurJHematol. 1992;49:260-262.
  • Chockalingam UM, Murphy E, OphovenJC, Weisdorf SA, Georgieff MK. Cord transferrin and ferritin values in newborn infants at risk for prenatal uteroplacental insufficiency and chronic hypoxia. JPediatr. 1987;111:283-286.
  • Carpani G, Marini F, Ghisoni L, Buscaglia M, Sinigaglia E, Moroni G. Red cell and plasma ferritin in a group of normal fetuses at different ages of gestation. EurJHematol. 1992;49:260-262.
  • Georgieff MK, Wewerka SW, Nelson CA, deRegnier R-A. Iron status at 9 months of infants with low iron stores at birth. JPediatr. 2002;141:405-409.
  • Thorp JA, O’Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 1991;165:79-81.
  • Ovali F, Samanci N, Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). PediatrRes. 1996;39:831-834.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.